A private executive network of CFOs and senior financial leaders collaborating at the intersection of innovation capital, biotech strategy, and enterprise value creation.
Del Mar Life Sciences was founded on a single conviction: the most powerful ideas in life sciences finance emerge when the right executives are in conversation with each other.
We bring together CFOs, VP Finance, and financial leadership from across biotechnology, healthcare, and medical innovation — creating the conditions for candid, high-value exchange that simply does not happen in broader forums.
Members compare notes on what works, stress-test strategies in a trusted environment, and build relationships that extend well beyond any single organization or transaction.
The life sciences sector demands a rare combination: scientific literacy, regulatory fluency, capital markets expertise, and the operational discipline to scale complex organizations. Our network exists to serve executives who carry all of these responsibilities simultaneously.
Robert Mowry brings decades of financial leadership within the life sciences ecosystem, having guided companies through pivotal moments — from early-stage capital formation through IPO readiness, board governance transitions, and long-term enterprise value creation. His experience spans corporate venture capital, pension management, and strategic financial operations across the biotech and healthcare spectrum.
Through Del Mar Life Sciences, Robert convenes a curated network of peers and provides advisory services to organizations seeking to elevate their financial sophistication and capital readiness.
Navigating venture rounds, crossover financing, debt capital markets, and IPO readiness with the strategic clarity that sophisticated investors demand.
Building and managing corporate venture vehicles, co-investment frameworks, portfolio governance, and the financial architecture of strategic investing arms.
Equipping financial leaders to engage effectively with boards, audit committees, and fiduciary bodies — including compensation, disclosure, and risk oversight.
Strategic management of pension obligations, employee benefits structures, and the long-term financial liabilities that shape enterprise health and talent retention.
Scaling finance functions alongside rapid organizational growth — from systems and controls architecture to treasury management, forecasting, and operational finance leadership.
Long-horizon thinking around M&A, licensing economics, platform asset valuation, and the financial narrative that underpins durable enterprise value in the life sciences sector.
Del Mar Life Sciences is intentionally selective. Membership is extended to senior financial executives — CFOs, Chief Accounting Officers, VP Finance, and equivalent roles — within the life sciences sector. We do not scale for scale's sake.
What members gain is something that no conference, subscription service, or advisory firm can replicate: genuine, peer-level dialogue with executives who navigate the same challenges, pressures, and opportunities at the same organizational level.
Our convenings are private, our conversations are candid, and our collective experience is deep. Members leave with sharper strategies, stronger networks, and the confidence that comes from knowing what their peers across the sector are actually doing.
Membership is by referral or direct invitation from Robert Mowry. If you are a senior financial leader in life sciences and believe Del Mar Life Sciences may be the right network for you, we welcome a confidential conversation.
Request an IntroductionMembership Criteria
Our members operate across every major segment of the life sciences ecosystem. The financial challenges in each sector carry unique complexity — and that diversity of experience is precisely what makes the Del Mar Life Sciences network so valuable.
Guidance on round structure, investor targeting, due diligence preparation, and the financial narrative required to raise capital efficiently at each stage of organizational growth.
Supporting executive teams and boards on governance structure, board composition, audit committee function, and the financial reporting disciplines that build institutional confidence.
Advisory on building finance functions commensurate with organizational ambition — systems, controls, talent, and process design that can sustain rapid growth without sacrificing integrity.
Designing and operationalizing corporate venture programs — from fund structure and investment thesis to portfolio governance, co-investment relationships, and financial integration.
The most important financial decisions in life sciences are rarely made alone. The leaders who raise the most capital, build the most durable organizations, and create the most enduring value are those who know precisely when to seek counsel and whose counsel to trust.
Whether you are exploring membership in the Del Mar Life Sciences network, seeking advisory support for your organization, or interested in connecting with Robert Mowry directly, we welcome your inquiry.